BindingDB logo
myBDB logout

BDBM168082 US9073931, E8b::US9073931, E8c

SMILES: CC(C)[C@H]1N(CCn2c1nc1cc(CO)c(cc21)S(C)(=O)=O)c1ncc(C(C)O)c(n1)C(F)(F)F

InChI Key: InChIKey=WAZXSGZGKNWHSO-VMHBGOFLSA-N

Data: 4 KI

Find this compound or compounds like it in BindingDB or PDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 4 hits for monomerid = 168082   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kcal/mole
IC50
nM
Kd
nM
EC50/IC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
Liver X receptor (LXR alpha AND LXR beta)


(Homo sapiens (human))
BDBM168082
PNG
(US9073931, E8b | US9073931, E8c)
Show SMILES CC(C)[C@H]1N(CCn2c1nc1cc(CO)c(cc21)S(C)(=O)=O)c1ncc(C(C)O)c(n1)C(F)(F)F
Show InChI InChI=1S/C22H26F3N5O4S/c1-11(2)18-20-27-15-7-13(10-31)17(35(4,33)34)8-16(15)29(20)5-6-30(18)21-26-9-14(12(3)32)19(28-21)22(23,24)25/h7-9,11-12,18,31-32H,5-6,10H2,1-4H3/t12?,18-/m1/s1
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars

74 -9.72n/an/an/an/an/an/a25



Vitae Pharmaceuticals, Inc.

US Patent


Assay Description
Compounds of the invention were assessed in a competition binding assay where different concentrations of compounds were incubated with the LXR ligan...


US Patent US9073931 (2015)


BindingDB Entry DOI: 10.7270/Q26W98VC
More data for this
Ligand-Target Pair
Liver X receptor (LXR alpha AND LXR beta)


(Homo sapiens (Human))
BDBM168082
PNG
(US9073931, E8b | US9073931, E8c)
Show SMILES CC(C)[C@H]1N(CCn2c1nc1cc(CO)c(cc21)S(C)(=O)=O)c1ncc(C(C)O)c(n1)C(F)(F)F
Show InChI InChI=1S/C22H26F3N5O4S/c1-11(2)18-20-27-15-7-13(10-31)17(35(4,33)34)8-16(15)29(20)5-6-30(18)21-26-9-14(12(3)32)19(28-21)22(23,24)25/h7-9,11-12,18,31-32H,5-6,10H2,1-4H3/t12?,18-/m1/s1
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars

9 -11.0n/an/an/an/an/an/a25



Vitae Pharmaceuticals, Inc.

US Patent


Assay Description
Compounds of the invention were assessed in a competition binding assay where different concentrations of compounds were incubated with the LXR ligan...


US Patent US9073931 (2015)


BindingDB Entry DOI: 10.7270/Q26W98VC
More data for this
Ligand-Target Pair
Liver X receptor (LXR alpha AND LXR beta)


(Homo sapiens (Human))
BDBM168082
PNG
(US9073931, E8b | US9073931, E8c)
Show SMILES CC(C)[C@H]1N(CCn2c1nc1cc(CO)c(cc21)S(C)(=O)=O)c1ncc(C(C)O)c(n1)C(F)(F)F
Show InChI InChI=1S/C22H26F3N5O4S/c1-11(2)18-20-27-15-7-13(10-31)17(35(4,33)34)8-16(15)29(20)5-6-30(18)21-26-9-14(12(3)32)19(28-21)22(23,24)25/h7-9,11-12,18,31-32H,5-6,10H2,1-4H3/t12?,18-/m1/s1
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars

13 -10.8n/an/an/an/an/an/a25



Vitae Pharmaceuticals, Inc.

US Patent


Assay Description
Compounds of the invention were assessed in a competition binding assay where different concentrations of compounds were incubated with the LXR ligan...


US Patent US9073931 (2015)


BindingDB Entry DOI: 10.7270/Q26W98VC
More data for this
Ligand-Target Pair
Liver X receptor (LXR alpha AND LXR beta)


(Homo sapiens (human))
BDBM168082
PNG
(US9073931, E8b | US9073931, E8c)
Show SMILES CC(C)[C@H]1N(CCn2c1nc1cc(CO)c(cc21)S(C)(=O)=O)c1ncc(C(C)O)c(n1)C(F)(F)F
Show InChI InChI=1S/C22H26F3N5O4S/c1-11(2)18-20-27-15-7-13(10-31)17(35(4,33)34)8-16(15)29(20)5-6-30(18)21-26-9-14(12(3)32)19(28-21)22(23,24)25/h7-9,11-12,18,31-32H,5-6,10H2,1-4H3/t12?,18-/m1/s1
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars

65 -9.80n/an/an/an/an/an/a25



Vitae Pharmaceuticals, Inc.

US Patent


Assay Description
Compounds of the invention were assessed in a competition binding assay where different concentrations of compounds were incubated with the LXR ligan...


US Patent US9073931 (2015)


BindingDB Entry DOI: 10.7270/Q26W98VC
More data for this
Ligand-Target Pair